This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Valueact Buys $3M Worth of Valeant Pharma

Stocks in this article: VRX PIR VMED

Which insiders are selling and buying chunks of stocks?

Below are lists of the top 10 open-market insider purchases and sales filed at the Securities and Exchange Commission Tuesday as ranked by dollar value. Company executives and directors are in the best position to assess the attractiveness of their firms' shares, and here is how many of them are voting their wallets! Please note, however, that these are factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction.

For the most up-to-date insider data, and fundamentally researched investment ideas inspired by insiders, check out

Company Name (Ticker) Filer Name
Valeant Pharmaceuticals (VRX) Valueact Holdings LP BO 139,100 $3,311,772
Pier 1 Imports (PIR) Greek Investments Inc BO 175,800 $313,767
Center Bancorp (CNBC) Seidman Lawrence B DIR 25,000 $204,730
Staples (SPLS) Sulentic Robert E DIR 10,000 $200,600
Breeze-Eastern (BZC) Tinicum Capital Partners II LP BO 30,000 $180,000
Global LP (GLP) Global Gp LLC DIR,PT 8,275 $153,998
Red Lion Hotels (RLH) Columbia Pacific Opportunity Fund LP BO 35,600 $152,212
Breeze-Eastern (BZC) Wynnefield Partners Small Cap Value LP I BO 20,000 $120,000
JER Investors Trust (JERT) Ejf Capital LLC BO 68,856 $40,625
JMP Group (JMP) Barton Harris DIR 5,000 $34,050
Company Name (Ticker) Filer Name
Virgin Media (VMED) Huff William R DIR 54,794 $494,938
Map Pharmaceuticals (MAPP) Firstmark Capital LLC O 38,421 $427,143
Texas Capital Bancshares (TCBI) Snyder John C X 25,000 $386,500
Coleman Cable (CCIX) Jana Partners LLC BO 72,374 $210,209
Haverty Furniture (HVT) Ridley Clarence H DIR 16,816 $155,487
Gladstone Commercial (GOOD) Brubaker Terry Lee DIR,COO 8,816 $123,576
Cardiovascular Biotherapeutics (CVBT) Stegmann Thomas BO 482,002 $98,328
AEP Industries (AEPI) JMB Capital Partners Master Fund LP BO 3,500 $94,598
Grubb & Ellis (GBE) Thompson Anthony W BO 84,979 $74,481
Dynavax Technologies (ADLR) BVF Partners L Pil BO 21,500 $42,970
Key to Titles: A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs